AmCad BioMed Corporation (4188)
Market Open
15 Oct, 05:30 AM
TWSE 
NT$
13. 10
-0.1
-0.7576%
NT$
- Market Cap
7.52 P/E Ratio
64% Div Yield
99,019 Volume
0 Eps
NT$ 13.2
Previous Close Want to track 4188 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AmCad BioMed Corporation (4188) Statistics
Valuation metrics
Market Cap -
Enterprise value 880.84M
Trailing P/E (ttm) -16.81
Forward P/E -
PEG ratio -8.35
Price/Sales (ttm) 30.89
Price/Book (mrq) 1.73
Enterprise Value/Revenue 30.8
Enterprise Value/EBITDA -13.23
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 113.05K
Average volume (90 days) 219.62K
Price summary
52-Week low 9.06
52-Week high 17.65
Beta -
50-Day moving average 14.12
200-Day moving average 11.77
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 29 Sep 2026
Ex-Dividend Date 29 Sep 2026
Last split factor 103:100
Last split Date 27 May 2016
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.99%
Operating margin -3.03%
Operational effectiveness
Return on assets -0.09%
Return on equity -0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.45
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.89
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.35
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 18.49%
Book value per share (mrq) 9.21
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
